Ubs Group Ag Organon & Co. Call Options Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	BUY	$13.78 - $18.8 $993,538 - $1.36 Million	72,100 New	72,100 $1.36 Million
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $41,284 - $53,467	-1,440 Reduced 96.64%	50 $2,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $8,617 - $10,727	-301 Reduced 16.81%	1,490 $49,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $50,953 - $68,058	1,791 New	1,791 $54,000

794

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.65B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.